Despite burgeoning research on psychedelics, best practices for their safe and effective use in and out of clinical settings are still poorly understood. Like psychedelics, meditation can involve non- ordinary states and psycho-spiritual impacts and has the potential for adverse effects despite well- recognized benefits. This talk will describe how meditation research can inform key questions in psychedelics, including monitoring adverse effects, addressing spirituality, and developing culturally responsive treatments.